While genomic alterations were prevalent in both malignancies, significant correlations between ABC transporter gene alterations and patient survival were observed exclusively in prostate cancer, whereas no such correlation on overall survival was found in breast cancer. This evidence concerns the gene ABCG2 and Familial prostate cancer.